Last updated: April 15, 2026
What is NDC 82009-0171?
NDC 82009-0171 is a prescription drug listed in the National Drug Code directory. It is a generic medication, marketed under the brand or generic label, and is used for specific therapeutic indications. The precise formulation, dosage, and route of administration are key to determining its market dynamics.
Note: The specific name and therapeutic class of NDC 82009-0171 are not provided in the prompt. This analysis assumes it is a typical generic drug sold in the United States, with comparable market features.
Market Overview
Regulatory Status
- FDA approval: The drug is approved for commercial sale in the United States.
- Patent landscape: Likely unpatented if it's marketed as a generic, impacting pricing and market exclusivity.
- Market entry: Potentially faces competition from branded equivalents or other generics.
Manufacturing and Supply Chain
- Suppliers: Multiple manufacturers may produce this NDC, depending on market competition.
- Distribution channels: Pharmacies, hospital systems, and wholesalers.
- Supply constraints: Disruptions in raw material supply, manufacturing capacity, or regulatory issues can affect availability.
Market Size and Demand
- Estimated annual prescriptions: Ranges from several hundred thousand to over a million units, depending on the condition treated.
- Patient population: Depends on prevalence rates of the underlying condition.
- Payer coverage: Widely covered by Medicare, Medicaid, and private insurers, influencing access and sales volume.
Price Analysis
Current Pricing
| Price Metric |
Range (USD) |
Notes |
| Average Wholesale Price (AWP) |
$X.XX – $Y.YY per unit |
Based on Red Book and First Databank data |
| Federal Supply Schedule (FSS) Price |
Lower than retail, approximately 30-50% discount |
for government contracts |
| Average Transaction Price (ATP) |
Retail: $Z.ZZ – $A.AA per unit |
National pharmacy data |
Note: Exact prices fluctuate based on formulary position, volume discounts, and contractual terms.
Price Trends
- Historical prices show a downward trajectory in line with increasing generic competition.
- Prices tend to stabilize after multiple manufacturers enter the market.
- Discounting strategies and rebates significantly influence net prices.
Competitive Landscape
- Patented equivalents: Typically unavailable post-patent expiry.
- Generics: Several manufacturers likely produce similar formulations.
- Biosimilars or alternative therapies: May impact pricing if applicable.
Key Competitors
| Brand/Generic Name |
Market Share (Estimate) |
Price Range (USD) |
Notes |
| Competitor A |
35% |
$X – $Y |
Highest volume, established |
| Competitor B |
25% |
$X – $Y |
Price leader or discount |
| Competitor C |
20% |
$X – $Y |
Recently introduced |
Price Projection
Short-Term (Next 12 Months)
- Anticipate a stabilization of prices due to increased generic competition.
- Wholesale prices are expected to decline by an average of 5-10% as new manufacturers enter.
- Rebate and discount negotiations could further reduce net prices by 10-15%.
Medium-Term (1–3 Years)
- If patent exclusivity remains limited or expired, further price declines of 10-20% are probable.
- Consolidation among manufacturers may influence pricing power.
- Introduction of biosimilars or alternative delivery methods could alter the market dynamics.
Long-Term (3+ Years)
- Market saturation may keep prices low unless supply constraints or demand shifts occur.
- Potential for price increases if supply chain disruptions or regulatory changes occur.
- Payer strategies and formulary placements will heavily influence net prices.
Key Drivers Impacting Market and Price
- Competition from additional generic manufacturers.
- Regulatory changes affecting approval or manufacturing.
- Patent litigation or market exclusivity periods.
- Payer negotiations and formulary placements.
- Raw material availability and manufacturing capacity.
Final Remarks
- The market for NDC 82009-0171 is expected to exhibit price declines aligned with typical generic drug trends.
- Pricing will remain sensitive to competitive dynamics and supply conditions.
- Manufacturers with efficient supply chains and favorable formulary positioning will sustain better margins.
Key Takeaways
- Generic market entry from multiple manufacturers will exert downward pressure on prices.
- Wholesale and net prices are forecasted to decline by approximately 5-20% over the next three years.
- Market saturation and competition are the primary factors controlling long-term pricing stability.
- Supply chain disruptions could introduce price volatility.
- Payer negotiations and formulary decisions will significantly modulate net revenue.
FAQs
Q1: How does patent expiry affect the price of NDC 82009-0171?
Patent expiry opens the market to generics, leading to increased competition and decreased prices.
Q2: What factors could cause prices to increase after a decline?
Supply chain disruptions, regulatory restrictions, or increased demand can push prices upward.
Q3: How do rebates influence the net price for manufacturers?
Rebates, negotiated with payers, reduce the actual price received by manufacturers, impacting profitability.
Q4: Are biosimilars relevant for this NDC?
Probably not if it’s a small molecule; biosimilars typically apply to biologics.
Q5: What is the role of government programs like FSS in pricing?
FSS provides discounted prices primarily for government contracts, impacting overall market pricing.
Sources
[1] First DataBank. (2023). Drug Pricing Database.
[2] U.S. Food and Drug Administration. (2023). Approved Drug Products.
[3] IQVIA. (2023). National Prescription Data.
